Lv3
340 积分 2021-03-11 加入
Prognostic significance of the early course of minimal change nephrotic syndrome
1个月前
已关闭
BILAG 2004. Development and initial validation of an updated version of the British Isles Lupus Assessment Group's disease activity index for patients with systemic lupus erythematosus
1个月前
已完结
Long-term outcome of adult-onset minimal-change nephropathy
1个月前
已完结
Adult-Onset Minimal Change Disease among Taiwanese
1个月前
已完结
Rituximab for Relapsing Nephrotic Syndrome in Adults
1个月前
已完结
Safety and efficacy of zilucoplan in patients with generalised myasthenia gravis (RAISE): a randomised, double-blind, placebo-controlled, phase 3 study
1个月前
已完结
Safety and efficacy of nipocalimab in adults with generalised myasthenia gravis (Vivacity-MG3): a phase 3, randomised, double-blind, placebo-controlled study
1个月前
已完结
Safety and efficacy of rozanolixizumab in patients with generalised myasthenia gravis (MycarinG): a randomised, double-blind, placebo-controlled, adaptive phase 3 study
1个月前
已完结
Safety, efficacy, and tolerability of efgartigimod in patients with generalised myasthenia gravis (ADAPT): a multicentre, randomised, placebo-controlled, phase 3 trial
1个月前
已完结
Rituximab for Relapsing Nephrotic Syndrome in Adults
1个月前
已关闭
皖公网安备34019202002308
